4
Changes in Ownership
Viking Therapeutics, Inc. Filed Acc 0001209191-23-024228
President & CEO sold 79,336 shares at $18.45 ($1,463,749)
- President & CEO acquired 54,336 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lian Brian · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-13 | Exercise or conversion : show line 1 in the form | +54,336 | $1.88 | $102,152 | 2,387,299 | D |
| 2023-04-13 | Sale : show line 2 in the form | −79,336 | $18.45 | $1,463,749 | 2,307,963 | D |
| Open-market sales · 79,336 sh · avg $18.45 · $1,463,749 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-13 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −54,336 | 0 | D |
Loading xslF345X04/doc4.xml…